LU86533A1 - Compositions pharmaceutiques antivirales et antitumorales - Google Patents
Compositions pharmaceutiques antivirales et antitumorales Download PDFInfo
- Publication number
- LU86533A1 LU86533A1 LU86533A LU86533A LU86533A1 LU 86533 A1 LU86533 A1 LU 86533A1 LU 86533 A LU86533 A LU 86533A LU 86533 A LU86533 A LU 86533A LU 86533 A1 LU86533 A1 LU 86533A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- compound
- acid
- sodium
- adjuvant
- group
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3527871 | 1985-08-02 | ||
DE3527871 | 1985-08-02 | ||
DE3620939 | 1986-06-23 | ||
DE3620939 | 1986-06-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
LU86533A1 true LU86533A1 (fr) | 1988-02-02 |
Family
ID=25834701
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU86533A LU86533A1 (fr) | 1985-08-02 | 1986-07-30 | Compositions pharmaceutiques antivirales et antitumorales |
Country Status (14)
Country | Link |
---|---|
US (1) | US4851435A (de) |
JP (1) | JPH0618786B2 (de) |
AU (1) | AU585380B2 (de) |
BE (1) | BE905195A (de) |
CA (1) | CA1295944C (de) |
CH (1) | CH673224A5 (de) |
DK (1) | DK369186A (de) |
FR (1) | FR2591483B1 (de) |
GB (1) | GB2178957B (de) |
GR (1) | GR862030B (de) |
IT (1) | IT1213453B (de) |
LU (1) | LU86533A1 (de) |
NL (1) | NL8601895A (de) |
SE (1) | SE501592C2 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT392906B (de) * | 1987-10-08 | 1991-07-10 | Hoffmann La Roche | Pharmazeutische praeparate zur oralen verabreichung |
CA2010511A1 (en) * | 1989-03-01 | 1990-09-01 | Roberto L. Ceriani | Method of enhancing cancer therapy by administration of unsaturated fatty acids |
WO1996014841A1 (en) * | 1994-11-14 | 1996-05-23 | Ct-Holding S.A. | Antiviral and antitumor pharmaceutical compositions |
DE10117728A1 (de) * | 2001-04-09 | 2002-10-17 | Biosphings Ag | Pharmazeutische Formulierungen für Xanthogenate |
DE10156617A1 (de) * | 2001-11-17 | 2003-05-28 | Biosphings Ag | Herstellung reiner Stereoisomere von Tricyclo[5.2.1.0··2··.··6··]-dec-9-yl-xanthogenat und Arzneimittel daraus |
DE10343365A1 (de) * | 2003-09-17 | 2005-04-14 | Biosphings Ag | Pharmazeutische Formulierungen von Xanthogenaten und Hemmstoffen der viralen Nukleinsäurereplikation |
EP2422789B1 (de) * | 2004-05-19 | 2017-11-22 | Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center | Injizierbare Zusammensetzung enthaltend Natrium Deoxycholate |
US7754230B2 (en) * | 2004-05-19 | 2010-07-13 | The Regents Of The University Of California | Methods and related compositions for reduction of fat |
US20060127468A1 (en) | 2004-05-19 | 2006-06-15 | Kolodney Michael S | Methods and related compositions for reduction of fat and skin tightening |
DE102006014390A1 (de) * | 2006-03-29 | 2007-10-04 | Biosphings Ag | Assoziate von Xanthogenaten mit Cyclodextrinen und ihre Verwendung |
CN101796024A (zh) * | 2007-07-03 | 2010-08-04 | 露马维塔股份公司 | 三环癸-9-基-黄原酸酯的立体异构体 |
US8101593B2 (en) | 2009-03-03 | 2012-01-24 | Kythera Biopharmaceuticals, Inc. | Formulations of deoxycholic acid and salts thereof |
MX363465B (es) | 2011-02-18 | 2019-03-25 | Kythera Biopharmaceuticals Inc | Tratamiento de la grasa submental. |
US8653058B2 (en) | 2011-04-05 | 2014-02-18 | Kythera Biopharmaceuticals, Inc. | Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4020183A (en) * | 1974-12-03 | 1977-04-26 | Ortho Pharmaceutical Corporation | Nonionic surface active anti-herpes simplex viral agents |
KR870001238B1 (ko) * | 1980-11-26 | 1987-06-26 | 메르츠+캄패니 게엠베하 앤드 캄패니 | 크산틴산염의 제조방법 |
CA1174978A (en) * | 1980-11-26 | 1984-09-25 | Arthur Scherm | Xanthates |
DK315482A (da) * | 1981-07-20 | 1983-01-21 | Kimberly Clark Co | Fremgangsmaade til hindring af spredning af aandedraetsvira og middel til anvendelse ved fremgangsmaaden |
-
1986
- 1986-07-21 IT IT8621192A patent/IT1213453B/it active
- 1986-07-22 NL NL8601895A patent/NL8601895A/nl not_active Application Discontinuation
- 1986-07-23 CH CH2960/86A patent/CH673224A5/de not_active IP Right Cessation
- 1986-07-29 AU AU60648/86A patent/AU585380B2/en not_active Ceased
- 1986-07-29 BE BE0/216195A patent/BE905195A/fr not_active IP Right Cessation
- 1986-07-30 LU LU86533A patent/LU86533A1/fr unknown
- 1986-07-30 CA CA000515025A patent/CA1295944C/en not_active Expired - Fee Related
- 1986-07-31 GR GR862030A patent/GR862030B/el unknown
- 1986-08-01 FR FR868611220A patent/FR2591483B1/fr not_active Expired - Fee Related
- 1986-08-01 DK DK369186A patent/DK369186A/da not_active Application Discontinuation
- 1986-08-01 US US06/892,346 patent/US4851435A/en not_active Expired - Lifetime
- 1986-08-01 GB GB8618820A patent/GB2178957B/en not_active Expired
- 1986-08-01 SE SE8603284A patent/SE501592C2/sv unknown
- 1986-08-01 JP JP61180216A patent/JPH0618786B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
GB8618820D0 (en) | 1986-09-10 |
BE905195A (fr) | 1987-01-29 |
SE8603284D0 (sv) | 1986-08-01 |
GR862030B (en) | 1986-12-24 |
JPH0618786B2 (ja) | 1994-03-16 |
SE501592C2 (sv) | 1995-03-20 |
FR2591483A1 (fr) | 1987-06-19 |
JPS6259223A (ja) | 1987-03-14 |
AU6064886A (en) | 1987-02-05 |
GB2178957B (en) | 1989-12-28 |
DK369186D0 (da) | 1986-08-01 |
CA1295944C (en) | 1992-02-18 |
CH673224A5 (de) | 1990-02-28 |
DK369186A (da) | 1987-02-03 |
IT8621192A0 (it) | 1986-07-21 |
NL8601895A (nl) | 1987-03-02 |
FR2591483B1 (fr) | 1990-08-10 |
AU585380B2 (en) | 1989-06-15 |
IT1213453B (it) | 1989-12-20 |
US4851435A (en) | 1989-07-25 |
SE8603284L (sv) | 1987-02-03 |
GB2178957A (en) | 1987-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU86533A1 (fr) | Compositions pharmaceutiques antivirales et antitumorales | |
US11298403B2 (en) | Therapeutic agent for inflammatory bowel disease | |
LU85639A1 (fr) | Compositions pharmaceutiques et procede de preparation de compositions de phosphatidylserine utilisables au traitement de desordres du systeme nerveux central sans exercer d'effets sur la coagulation du sang | |
US20210177775A1 (en) | Method for the treatment of fatty liver disease | |
FR2482093A1 (fr) | Nouveaux derives d'ocytocine et compositions pharmaceutiques contenant ces derives | |
FR2468365A1 (fr) | Preparations de n4-acylcytosine arabinoside et composition pharmaceutique les contenant | |
EP0069659B1 (de) | Arzneimittel die das Reaktionprodukt von einer Carbonsäure und einer basischen Amino-säure enthalten | |
EP1231916A2 (de) | Verwendung von indirubinderivaten zur herstellung von medikamenten | |
KR20160099716A (ko) | 간 질환의 치료 방법 | |
WO1993010792A1 (fr) | Utilisation de la creatine phosphate ou de l'acide phosphoenol pyruvique pour le traitement des tumeurs | |
EP3137099B1 (de) | Dnase zur verwendung in der behandlung von gefässokklusiver krise | |
WO2021256547A1 (ja) | SARS-CoV-2感染症の治療、予防または緩和用組成物 | |
KR20100015986A (ko) | 지방간 또는 비알코올성 지방성 간염의 예방 및/또는 치료를 위한 의약 | |
JP7446587B2 (ja) | 抗ヒトノロウイルス剤 | |
JP2013103925A (ja) | 肝臓線維化抑制剤 | |
EP0149847A2 (de) | Dolichol enthaltendes therapeutisches und vorbeugendes Mittel | |
US20100292186A1 (en) | Pharmaceutical Composition for Treatment or Prevention of Liver Cancer | |
EP3648768B1 (de) | Imeglimin zur prävention und/oder behandlung von leberzellkarzinomen | |
KR100356899B1 (ko) | 궤양성 대장염 및/또는 크론병 예방 및 치료제 | |
JPH01211528A (ja) | 抗hiv剤 | |
FR2733913A1 (fr) | Sequence d'adn a titre de medicament, et compositions pharmaceutiques en contenant | |
TW202327566A (zh) | 包含藻褐素及小分子褐藻醣膠之組合物用於製備治療或改善慢性腎病之醫藥品的用途及包含藻褐素、小分子褐藻醣膠及左旋肉鹼之組合物及包含其的醫藥品 | |
CA3191058A1 (en) | Peptide inhibitors of nf kappa b and use thereof in treatment of covid-19 and inflammatory diseases | |
CN115957302A (zh) | 一种复合制剂LL-37-cGAMP及其制备方法和应用 | |
CS275793B6 (en) | Production method of the antivirus and antitumour agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DT | Application date | ||
TA | Annual fee |